Review



bfgf (stem cell technology, cat. no. 788003.1)  (STEMCELL Technologies Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    STEMCELL Technologies Inc bfgf (stem cell technology, cat. no. 788003.1)
    Flow chart of sequential procedure used to produce cholinergic cells derived from human neural stem cells in adherent culture. The protocol involves daily medium change with increasing concentration of NGF and decreasing concentration <t>of</t> <t>EGF,</t> <t>bFGF,</t> and B-27. The medium on day 10 was kept constant for the next four days. The protocol is previously described by .
    Bfgf (Stem Cell Technology, Cat. No. 788003.1), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bfgf (stem cell technology, cat. no. 788003.1)/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    bfgf (stem cell technology, cat. no. 788003.1) - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Differentiation of Human Embryonic Stem Cells into Neuron, Cholinergic, and Glial Cells"

    Article Title: Differentiation of Human Embryonic Stem Cells into Neuron, Cholinergic, and Glial Cells

    Journal: Stem Cells International

    doi: 10.1155/2020/8827874

    Flow chart of sequential procedure used to produce cholinergic cells derived from human neural stem cells in adherent culture. The protocol involves daily medium change with increasing concentration of NGF and decreasing concentration of EGF, bFGF, and B-27. The medium on day 10 was kept constant for the next four days. The protocol is previously described by .
    Figure Legend Snippet: Flow chart of sequential procedure used to produce cholinergic cells derived from human neural stem cells in adherent culture. The protocol involves daily medium change with increasing concentration of NGF and decreasing concentration of EGF, bFGF, and B-27. The medium on day 10 was kept constant for the next four days. The protocol is previously described by .

    Techniques Used: Derivative Assay, Concentration Assay



    Similar Products

    bfgf (stem cell technology, cat. no. 788003.1)  (STEMCELL Technologies Inc)
    90
    STEMCELL Technologies Inc bfgf (stem cell technology, cat. no. 788003.1)
    Flow chart of sequential procedure used to produce cholinergic cells derived from human neural stem cells in adherent culture. The protocol involves daily medium change with increasing concentration of NGF and decreasing concentration <t>of</t> <t>EGF,</t> <t>bFGF,</t> and B-27. The medium on day 10 was kept constant for the next four days. The protocol is previously described by .
    Bfgf (Stem Cell Technology, Cat. No. 788003.1), supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bfgf (stem cell technology, cat. no. 788003.1)/product/STEMCELL Technologies Inc
    Average 90 stars, based on 1 article reviews
    bfgf (stem cell technology, cat. no. 788003.1) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Flow chart of sequential procedure used to produce cholinergic cells derived from human neural stem cells in adherent culture. The protocol involves daily medium change with increasing concentration of NGF and decreasing concentration of EGF, bFGF, and B-27. The medium on day 10 was kept constant for the next four days. The protocol is previously described by .

    Journal: Stem Cells International

    Article Title: Differentiation of Human Embryonic Stem Cells into Neuron, Cholinergic, and Glial Cells

    doi: 10.1155/2020/8827874

    Figure Lengend Snippet: Flow chart of sequential procedure used to produce cholinergic cells derived from human neural stem cells in adherent culture. The protocol involves daily medium change with increasing concentration of NGF and decreasing concentration of EGF, bFGF, and B-27. The medium on day 10 was kept constant for the next four days. The protocol is previously described by .

    Article Snippet: DMEM/F12 (Thermo Fisher Scientific, Cat. No 11320033) medium together with increasing concentration of NGF-beta (Stem Cell Technology, Cat. No. 78092) and reducing concentration of B-27™ Supplement, EGF (Stem Cell Technology, Cat. No. 78006), and BFGF (Stem Cell Technology, Cat. No. 788003.1) was used as complete differentiation medium.

    Techniques: Derivative Assay, Concentration Assay